Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Total Shareholders' Equity	Preferred Shares	Common Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Distributions in Excess of Retained Earnings	Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2021			29,600,000	130,813,750
Beginning balance at Dec. 31, 2021	$ 3,163,905	$ 3,156,181	$ 296	$ 1,308	$ 4,268,042	$ (19,442)	$ (1,094,023)	$ 7,724
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemption of preferred shares (in shares)			(1,000,000)
Redemption of preferred shares	(16,000)	(16,000)	$ (10)		(24,176)		8,186
Issuance of shares, net of offering costs (in shares)			0
Issuance of shares, net of offering costs	(123)	(123)	$ 0		(123)
Issuance of operating partnership units	78,000							78,000
Issuance of common shares for Board of Trustees compensation (in shares)				33,866
Issuance of common shares for Board of Trustees compensation	738	738		$ 1	737
Repurchase of common shares (in shares)				(4,609,626)
Repurchase of common shares	(70,724)	(70,724)		$ (47)	(70,677)
Share-based compensation (in shares)				107,303
Share-based compensation	11,350	8,557		$ 1	8,556			2,793
Distributions on common shares/units	(5,104)	(5,035)					(5,035)	(69)
Distributions on preferred shares/units	(48,049)	(45,074)					(45,074)	(2,975)
Other comprehensive income (loss):
Change in fair value of derivative instruments	55,479	55,114				55,114		365
Amounts reclassified from other comprehensive income	52	52				52
Net income (loss)	(84,981)	(87,171)					(87,171)	2,190
Ending balance (in shares) at Dec. 31, 2022			28,600,000	126,345,293
Ending balance at Dec. 31, 2022	3,084,543	2,996,515	$ 286	$ 1,263	4,182,359	35,724	(1,223,117)	88,028
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Redemption of preferred shares (in shares)			(1,000,000)
Redemption of preferred shares	(15,790)	(15,790)	$ (10)		(24,176)		8,396
Redemption of non-controlling interest OP units (in shares)				133,605
Redemption of non-controlling interest OP units	0	3,515		$ 1	3,514			(3,515)
Issuance of common shares for Board of Trustees compensation (in shares)				55,480
Issuance of common shares for Board of Trustees compensation	754	754		$ 1	753
Repurchase of common shares (in shares)				(6,578,436)
Repurchase of common shares	(92,753)	(92,753)		$ (65)	(92,688)
Share-based compensation (in shares)				235,407
Share-based compensation	12,545	9,152		$ 2	9,150			3,393
Distributions on common shares/units	(4,949)	(4,877)					(4,877)	(72)
Distributions on preferred shares/units	(48,306)	(43,649)					(43,649)	(4,657)
Other comprehensive income (loss):
Change in fair value of derivative instruments	17,572	17,645				17,645		(73)
Amounts reclassified from other comprehensive income	(28,995)	(28,995)				(28,995)
Net income (loss)	(74,276)	(78,017)					(78,017)	3,741
Ending balance (in shares) at Dec. 31, 2023			27,600,000	120,191,349
Ending balance at Dec. 31, 2023	2,850,345	2,763,500	$ 276	$ 1,202	4,078,912	24,374	(1,341,264)	86,845
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common shares for Board of Trustees compensation (in shares)				47,497
Issuance of common shares for Board of Trustees compensation	745	745		$ 1	744
Repurchase of common shares (in shares)				(1,242,644)
Repurchase of common shares	(16,851)	(16,851)		$ (13)	(16,838)
Share-based compensation (in shares)				289,192
Share-based compensation	13,602	9,450		$ 3	9,447			4,152
Distributions on common shares/units	(4,902)	(4,829)					(4,829)	(73)
Distributions on preferred shares/units	(47,182)	(42,525)					(42,525)	(4,657)
Other comprehensive income (loss):
Change in fair value of derivative instruments	15,102	15,177				15,177		(75)
Amounts reclassified from other comprehensive income	(23,001)	(23,001)				(23,001)
Net income (loss)	16	(4,242)					(4,242)	4,258
Ending balance (in shares) at Dec. 31, 2024			27,600,000	119,285,394
Ending balance at Dec. 31, 2024	$ 2,787,874	$ 2,697,424	$ 276	$ 1,193	$ 4,072,265	$ 16,550	$ (1,392,860)	$ 90,450